EUR 15.55
(-4.01%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -5.33 Million EUR | 65.52% |
2022 | -15.47 Million EUR | -123.25% |
2021 | -6.93 Million EUR | -139.94% |
2020 | 17.36 Million EUR | 655.77% |
2019 | 2.29 Million EUR | 109.1% |
2018 | -25.23 Million EUR | -74.36% |
2017 | -14.47 Million EUR | -150.33% |
2016 | -5.78 Million EUR | -2355.51% |
2015 | -235.44 Thousand EUR | 37.55% |
2014 | -377 Thousand EUR | -110.31% |
2013 | 3.65 Million EUR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 1.3 Million EUR | 0.0% |
2023 FY | -5.33 Million EUR | 65.52% |
2023 Q4 | -5.33 Million EUR | 0.0% |
2023 Q2 | -7.68 Million EUR | 0.0% |
2022 Q4 | -15.47 Million EUR | 0.0% |
2022 Q2 | -6.85 Million EUR | 0.0% |
2022 FY | -15.47 Million EUR | -123.25% |
2021 Q4 | -6.93 Million EUR | 0.0% |
2021 FY | -6.93 Million EUR | -139.94% |
2021 Q2 | -13.05 Million EUR | 0.0% |
2020 FY | 17.36 Million EUR | 655.77% |
2020 Q2 | 1.24 Million EUR | 0.0% |
2020 Q4 | 17.36 Million EUR | 0.0% |
2019 FY | 2.29 Million EUR | 109.1% |
2019 Q2 | -2.75 Million EUR | 0.0% |
2019 Q4 | 2.29 Million EUR | 0.0% |
2018 Q2 | -16.51 Million EUR | 0.0% |
2018 Q4 | -25.23 Million EUR | 0.0% |
2018 FY | -25.23 Million EUR | -74.36% |
2017 Q2 | -3.47 Million EUR | 0.0% |
2017 Q4 | -14.47 Million EUR | 0.0% |
2017 FY | -14.47 Million EUR | -150.33% |
2016 Q4 | -5.79 Million EUR | 0.0% |
2016 FY | -5.78 Million EUR | -2355.51% |
2016 Q2 | -322.34 Thousand EUR | 0.0% |
2015 Q4 | -396.2 Thousand EUR | 0.0% |
2015 FY | -235.44 Thousand EUR | 37.55% |
2015 Q2 | 379.69 Thousand EUR | 0.0% |
2014 FY | -377 Thousand EUR | -110.31% |
2013 FY | 3.65 Million EUR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Fresenius Medical Care AG & Co. KGaA | 10.64 Billion EUR | 100.05% |
Fresenius SE & Co. KGaA | 13.54 Billion EUR | 100.039% |
LIMES Schlosskliniken AG | 1.57 Million EUR | 439.666% |
Maternus-Kliniken Aktiengesellschaft | 111.79 Million EUR | 104.773% |
MEDICLIN Aktiengesellschaft | 364.53 Million EUR | 101.464% |
RHÖN-KLINIKUM Aktiengesellschaft | -56.2 Million EUR | 90.505% |
VITA 34 AG | 4.15 Million EUR | 228.317% |